Improving outcomes for cancer survivors with testosterone therapy
Official title: Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer
Funded at Seattle Inst for Biomedical/clinical Res · NIH-11143700 · Data updated 2026-11-12
This study is looking at whether testosterone replacement therapy can help young male cancer survivors who feel tired and have other health issues due to low testosterone levels, by checking if it improves their energy, sexual health, quality of life, and physical strength.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Seattle Inst for Biomedical/clinical Res NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | May 8, 2019 |
| Project end | April 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $517,115 |
| NIH project number | 5R01CA239208-06 |
| Project ID | NIH-11143700 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are young male cancer survivors who report fatigue and have been diagnosed with testosterone deficiency.
✕Less likely to help
Patients who are not male cancer survivors or those who do not have testosterone deficiency may not benefit from this research.
What this research studies
This research investigates the effects of testosterone replacement therapy on fatigue and other important health outcomes in young male cancer survivors who experience testosterone deficiency. The study will utilize a double-blind, randomized, placebo-controlled trial design, meaning that neither the participants nor the researchers will know who receives the actual treatment versus a placebo. Participants will be monitored for improvements in fatigue, sexual function, quality of life, body composition, muscle strength, and physical activity levels. The goal is to determine if testosterone therapy can alleviate debilitating symptoms that persist after cancer treatment.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for cancer survivors suffering from fatigue and related symptoms.
How similar studies have gone: Previous trials have shown that testosterone replacement therapy can improve fatigue and related symptoms in non-cancer populations, suggesting potential for success in this novel application.
Where this research is happening
-
Seattle Inst for Biomedical/clinical Res
Seattle, United States Active
Researchers
- Principal investigator: Garcia, Jose M. — Seattle Inst for Biomedical/clinical Res
- Study coordinator: Garcia, Jose M.
Related research
Other NIH-funded projects on the same topics.
-
Military Service–Linked ALS Risk in U.S. Veterans
This NIH grant investigates why U.S. veterans get ALS more often, by studying military exposures and health records to identify potential risk factors.
-
Targeting MSUT2 with small molecules to slow tau-related dementia
Aims to test whether small molecules that block MSUT2’s interaction with RNA can slow or reverse tau-related brain damage in people affected by Alzheimer’s disease and related dementias.
-
SPOP's role in tau-related brain disease
Researchers are studying how a protein called SPOP affects tau-related brain damage in Alzheimer's-type conditions, using a small worm model to mirror human disease and look for ways to protect brain cells.
-
Comparing medicines and weight-loss surgery for liver disease linked to metabolic problems
This program looks at how two drugs and bariatric surgery work for adults with metabolic dysfunction–associated steatohepatitis (MASH) and liver fibrosis.
-
Dementia with Lewy Bodies Consortium
A national research effort to better understand and diagnose Lewy body dementia by studying biomarkers and patient data over time.
-
Post-TBI Sleep Problems and Alzheimer’s/CTE Brain Changes
This grant studies whether sleep disruption after a traumatic brain injury increases the risk of Alzheimer’s disease and related brain changes later on, with a focus on people who’ve had mTBI.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.